Nardev Ramanathan supports Lux Research’s coverage of Digital Health and Wellness and is a key contributor to the Digital Transformation team. Nardev has deep expertise in genomics and precision medicine.
Prior to joining Lux, Nardev was the Assistant Head of the Industrial Development Group at the Agency for Science, Technology, and Research (A*STAR), Singapore where he was the Precision Medicine and Digital Health lead. In that role, he helped develop an industry consortium to support the local biotech ecosystem for Precision Medicine related initiatives in Singapore.
Nardev received his Ph.D. in Clinical Biochemistry from the University of Cambridge under the A*STAR Overseas Ph.D. scholarship. For his doctoral thesis, he identified a novel genetic mutation that leads to a rare inherited disease called lipodystrophy in a patient in the Middle East and further went on to elucidate the molecular mechanism underlying the disease.